Source link : https://newshealth.biz/health-news/bispecific-antibody-induces-high-response-rate-in-metastatic-tnbc/
(MedPage Today) — SAN ANTONIO — More than 70% of patients with advanced triple-negative breast cancer (TNBC) responded to an investigational bispecific antibody targeting PD-L1 and VEGF-A plus chemotherapy, a preliminary study showed. Overall… Source link : https://www.medpagetoday.com/meetingcoverage/sabcs/119040 Author : Publish date : 2025-12-16 16:30:00 Copyright for syndicated content belongs to the linked Source.
The post Bispecific Antibody Induces High Response Rate in Metastatic TNBC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-16 16:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8